14-23357617-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_005864.4(EFS):​c.1295A>G​(p.Asp432Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000000708 in 1,411,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

EFS
NM_005864.4 missense

Scores

5
10
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.43

Publications

0 publications found
Variant links:
Genes affected
EFS (HGNC:16898): (embryonal Fyn-associated substrate) The protein encoded by this gene is a member of the CAS (CRK-associated substrate) family of adaptor proteins which typically serve as scaffolds for the assembly of larger signaling complexes. These complexes form at the cell surface where integrin binding leads to the subsequent phosphorylation of a CAS protein. Additional binding of SRC family kinases leads to CAS hyperphosphorylation and the creation of binding sites for CRK and other proteins that cause actin cytoskeleton reorganization. This gene plays a role in integrin-mediated cell attachment, spreading, and migration and also plays a role in both normal and malignant cellular transformation. This broadly expressed gene has been shown to play a role in neurite outgrowth and its expression in the thymus and lymphocytes is important for T cell maturation and the development of immunological self-tolerance. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.837

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFSNM_005864.4 linkc.1295A>G p.Asp432Gly missense_variant Exon 6 of 6 ENST00000216733.8 NP_005855.1 O43281-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFSENST00000216733.8 linkc.1295A>G p.Asp432Gly missense_variant Exon 6 of 6 1 NM_005864.4 ENSP00000216733.3 O43281-1
EFSENST00000351354.3 linkc.1016A>G p.Asp339Gly missense_variant Exon 5 of 5 1 ENSP00000340607.3 O43281-2
EFSENST00000429593.6 linkc.788A>G p.Asp263Gly missense_variant Exon 6 of 6 2 ENSP00000416684.2 O43281-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.08e-7
AC:
1
AN:
1411632
Hom.:
0
Cov.:
31
AF XY:
0.00000144
AC XY:
1
AN XY:
694144
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32604
American (AMR)
AF:
0.00
AC:
0
AN:
42346
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23428
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38704
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78940
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51918
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5472
European-Non Finnish (NFE)
AF:
9.26e-7
AC:
1
AN:
1080098
Other (OTH)
AF:
0.00
AC:
0
AN:
58122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 01, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1295A>G (p.D432G) alteration is located in exon 6 (coding exon 6) of the EFS gene. This alteration results from a A to G substitution at nucleotide position 1295, causing the aspartic acid (D) at amino acid position 432 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T;.;.
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Benign
0.053
D
MetaRNN
Pathogenic
0.84
D;D;D
MetaSVM
Benign
-0.63
T
MutationAssessor
Pathogenic
3.3
M;.;.
PhyloP100
6.4
PrimateAI
Uncertain
0.52
T
PROVEAN
Pathogenic
-5.4
D;D;D
REVEL
Uncertain
0.44
Sift
Uncertain
0.0050
D;D;D
Sift4G
Pathogenic
0.0
D;T;D
Polyphen
1.0
D;.;D
Vest4
0.80
MutPred
0.61
Loss of sheet (P = 0.0457);.;.;
MVP
0.67
MPC
0.61
ClinPred
1.0
D
GERP RS
4.7
Varity_R
0.85
gMVP
0.82
Mutation Taster
=14/86
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1889970878; hg19: chr14-23826826; API